References
- Antes LM, Fernandez PC. Principles of diuretic therapy. Disease-A-Month 1998;44:254-268. https://doi.org/10.1016/S0011-5029(98)90003-7
- Mount DB, Yu ASL. Brenner and Rector's the Kidney. 8th ed. St Louis: WB Saunders, 2007.
- Ellison DH, Wilcox CS. Brenner and Rector's the Kidney. 8th ed. St Louis, WB Saunders, 2007.
- Bhardwaj A. Osmotherapy in neurocritical care. Curr Neurol Neurosci Rep 2007;7:513-521. https://doi.org/10.1007/s11910-007-0079-2
- Brater DC. Diuretic therapy. N Engl J Med 1998;339:387-395. https://doi.org/10.1056/NEJM199808063390607
- Shankar SS, Brater DC. Loop diuretics: from the Na-K-2Cl transporter to clinical use. Am J Physiol Renal Physiol 2003;284:F11-F21. https://doi.org/10.1152/ajprenal.00119.2002
- Wilcox CS. New insights into diuretic use in patients with chronic renal disease. J Am Soc Nephrol 2002;13:798-805.
- Sarafidis PA, Georgianos PI, Lasaridis AN. Diuretics in clinical practice. Part I: mechanisms of action, pharmacological effects and clinical indications of diuretic compounds. Expert Opin Drug Saf 2010;9:243-257. https://doi.org/10.1517/14740330903499240
- Ernst ME, Moser M. Use of diuretics in patients with hypertension. N Engl J Med 2009;361:2153-2164. https://doi.org/10.1056/NEJMra0907219
- Shah SU, Anjum S, Littler WA. Use of diuretics in cardiovascular diseases: (1) heart failure. Postgrad Med J 2004;80:201-205. https://doi.org/10.1136/pgmj.2003.010835
- The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2002;288:2981-2997. https://doi.org/10.1001/jama.288.23.2981
- Asare K. Management of loop diuretic resistance in the intensive care unit. Am J Health Syst Pharm 2009;66:1635-1640. https://doi.org/10.2146/ajhp090068